Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5854)
All Articles published online
|
Publishing Process of This Article
|
May 21, 2016 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Han QY, Liu ZW. Current treatment of chronic hepatitis C in China: Dilemma and potential problems. World J Gastroenterol 2016; 22(19): 4615-4618 [PMID: 27217693 DOI: 10.3748/wjg.v22.i19.4615] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i19/4615.htm |
| Number | Citing Articles |
| 1 |
Shu Su, Christopher K. Fairley, Joe Sasadeusz, Jianmei He, Xiuqing Wei, Huan Zeng, Jun Jing, Limin Mao, Xi Chen, Lei Zhang. HBV, HCV, and HBV/HCV co‐infection among HIV‐positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome. Journal of Medical Virology 2018; 90(3): 518 doi: 10.1002/jmv.24988
|
| 2 |
Erica Godinho Menezes, Jordana Grazziela Alves Coelho-dos-Reis, Ludmila Melo Cardoso, Ágata Lopes-Ribeiro, Juan Jonathan-Gonçalves, Marco Túlio Porto Gonçalves, Rodrigo Dias Cambraia, Eric Bassetti Soares, Luciana Diniz Silva, Vanessa Peruhype-Magalhães, Maria Rios, Caren Chancey, Andréa Teixeira-Carvalho, Olindo Assis Martins-Filho, Rosângela Teixeira. Strategies for serum chemokine/cytokine assessment as biomarkers of therapeutic response in HCV patients as a prototype to monitor immunotherapy of infectious diseases. Antiviral Research 2017; 141: 19 doi: 10.1016/j.antiviral.2017.02.001
|
| 3 |
Wen Chen, Thomas Ward, Mai Ping Tan, Jing Yan, Peter Feng Wang, Gail D Wygant, Jason Gordon. Daclatasvir combined with asunaprevir is a cost-effective and cost-saving treatment for hepatitis C infection in China. Journal of Comparative Effectiveness Research 2018; 7(8): 785 doi: 10.2217/cer-2018-0005
|
| 4 |
Shiyu Cao, Fuqiang Liu, Tingting Wang, Yaqing Tan, Shujun Liu, Yuan Liu, Lidong Gao, Lizhang Chen. New patterns emerge after a sustained increase in the incidence of hepatitis C virus infection from 2004 to 2017: a joinpoint regression analysis. Public Health 2019; 170: 49 doi: 10.1016/j.puhe.2019.01.014
|
| 5 |
Jian-Hong Chen, Zheng Zeng, Xia-Xia Zhang, Yu Zhang, Ren-Wen Zhang, Shuai Wang, Chi-Hong Wu, Min Yu, Dan Liu, Hong-Li Xi, Yi-Xing Zhou, Yao-Yu An, Xiao-Yuan Xu. Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting. World Journal of Gastroenterology 2017; 23(22): 4072-4079 doi: 10.3748/wjg.v23.i22.4072
|
| 6 |
Zobair M Younossi, Maria Stepanova, Tarik Asselah, Graham Foster, Keyur Patel, Norbert Bräu, Mark Swain, Tram Tran, Rafael Esteban, Massimo Colombo, Stephen Pianko, Linda Henry, Marc Bourliere. Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes. Clinical Infectious Diseases 2018; 66(11): 1742 doi: 10.1093/cid/cix1106
|
| 7 |
Jinyu Liu, Yu Zhang, Bin Wu, Sen Wang, David Bin-Chia Wu, Ruxu You. Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.717504
|